CYTK
Price
$48.53
Change
-$0.42 (-0.86%)
Updated
Dec 24 closing price
57 days until earnings call
MRUS
Price
$42.41
Change
-$0.04 (-0.09%)
Updated
Dec 24 closing price
69 days until earnings call
Ad is loading...

CYTK vs MRUS

Header iconCYTK vs MRUS Comparison
Open Charts CYTK vs MRUSBanner chart's image
Cytokinetics
Price$48.53
Change-$0.42 (-0.86%)
Volume$318.99K
CapitalizationN/A
Merus
Price$42.41
Change-$0.04 (-0.09%)
Volume$292.19K
CapitalizationN/A
CYTK vs MRUS Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. MRUS commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Buy and MRUS is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (CYTK: $48.53 vs. MRUS: $42.41)
Brand notoriety: CYTK and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 26% vs. MRUS: 52%
Market capitalization -- CYTK: $5.73B vs. MRUS: $2.9B
CYTK [@Biotechnology] is valued at $5.73B. MRUS’s [@Biotechnology] market capitalization is $2.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than MRUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while MRUS’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 5 bearish.
  • MRUS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CYTK and MRUS are a bad buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а +1.57% price change this week, while MRUS (@Biotechnology) price change was -5.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 20, 2025.

MRUS is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.73B) has a higher market cap than MRUS($2.9B). MRUS YTD gains are higher at: 54.218 vs. CYTK (-41.873). MRUS has higher annual earnings (EBITDA): -228.46M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. MRUS (632M). MRUS has less debt than CYTK: MRUS (11M) vs CYTK (790M). MRUS has higher revenues than CYTK: MRUS (35.9M) vs CYTK (3.22M).
CYTKMRUSCYTK / MRUS
Capitalization5.73B2.9B197%
EBITDA-481.94M-228.46M211%
Gain YTD-41.87354.218-77%
P/E RatioN/AN/A-
Revenue3.22M35.9M9%
Total Cash1.01B632M160%
Total Debt790M11M7,182%
FUNDAMENTALS RATINGS
CYTK vs MRUS: Fundamental Ratings
CYTK
MRUS
OUTLOOK RATING
1..100
1463
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
4723
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5657
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
6585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRUS's Valuation (56) in the Biotechnology industry is somewhat better than the same rating for CYTK (100). This means that MRUS’s stock grew somewhat faster than CYTK’s over the last 12 months.

MRUS's Profit vs Risk Rating (23) in the Biotechnology industry is in the same range as CYTK (47). This means that MRUS’s stock grew similarly to CYTK’s over the last 12 months.

MRUS's SMR Rating (97) in the Biotechnology industry is in the same range as CYTK (100). This means that MRUS’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (56) in the Biotechnology industry is in the same range as MRUS (57). This means that CYTK’s stock grew similarly to MRUS’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for MRUS (100). This means that CYTK’s stock grew significantly faster than MRUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKMRUS
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSSC69.830.58
+0.84%
Goldman Sachs ActiveBeta® US SmCp Eq ETF
DEEF28.300.03
+0.11%
Xtrackers FTSE Develop ex US Mulfact ETF
TOTL39.32N/A
N/A
SPDR® DoubleLine® Total Return Tact ETF
ULE10.50-0.06
-0.57%
ProShares Ultra Euro
YANG65.61-2.32
-3.42%
Direxion Daily FTSE China Bear 3X ETF

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with CYTK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-0.09%
CYTK - MRUS
35%
Loosely correlated
-0.86%
IMTX - MRUS
35%
Loosely correlated
+0.42%
VCYT - MRUS
34%
Loosely correlated
+0.46%
XENE - MRUS
33%
Poorly correlated
+0.73%
GOSS - MRUS
33%
Poorly correlated
-1.64%
More